Arylamine substututed bicyclic heteroaromatic compounds as P38 kinase inhibitors

Details for Australian Patent Application No. 2003253087 (hide)

International Classifications

Event Publications

30 October 2003 Complete Application Filed

Priority application(s): 0214268.5 20.06.02 GB

4 March 2004 Application Open to Public Inspection

Published as AU-B-2003253087

14 February 2008 Assignment before Grant

Celltech R&D Limited The application has been assigned to UCB Pharma S.A.

16 October 2008 Application Accepted

Published as AU-B-2003253087

12 February 2009 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.